Copapred is a in particular formulated injection for safety, control and remedy of muscle problems of horses. It is used as an useful resource with inside the manage of muscular dystrophy, and a muscular stimulant, in horses and dogs.
High efficiency formulation
Proven Australian and International product for horses
A muscle safety and tonic
Replacement for Kynoselen (for evaluation see connected table)
For racing, staying power, sport, stud and touring horses
Administer often to assist save you episodes of ‘tying up’ in horses
The energetic ingredients of Copapred Injection are:Copapred
ATP (adenosine triphosphate), imparting an instantaneous supply of muscle strength.
URDINE TRIPHOSPHATE is a supply of muscle strength, associated with ATP.
Copapred will increase blood float for exercising and staying power capacity. It enables construct and keep muscles. A new examine suggests HEPTAMINOL delays the onset of muscle fatigue.Copapred
VITAMIN B12 (cyanocobalamin) to stimulate urge for food for strength metabolism.Copapred
SELENIUM is an critical hint element. For metabolic processes, and strength. Selenium has anti-oxidant properties, protects muscle from damage. It at once and not directly prevents ‘tying-up’ and associated muscle problems.
MAGNESIUM ASPARTATE will increase oxygen shipping to muscle tissue. For muscle energy and staying power, and has a function in muscle contraction.Copapred
POTASSIUM ASPARTATE for glucose/glycogen (i.e., strength) metabolism.
DIRECTIONS FOR USE:
Inject slowly subcutaneously or intramuscularly.
Horses: four mL according to a hundred kg bodyweight.
Dogs: 1 mL according to 25 kg bodyweight.
Prevention: One injection every week for 2-three weeks.
Treatment: One Injection each three days for 9-12 days.
MEAT WITHHOLDING PERIOD: DO NOT ADMINISTER much less than 28 days earlier than slaughter for human consumption.
RACING/EVENT WITHHOLDING: Consult racing authorities, stewards, or veterinarians for the withholding time after remedy and earlier than racing or event.
There are no reviews yet.